CD28 and neoplasm: The BCMA-CD28-IL15 CAR-NK cells revealed stronger cytotoxicity and higher cytokine secretion against BCMA<sup>+</sup> tumor cells than BCMA-2B4-IL15 CAR-NK cells in vitro.